Mereo BioPharma Group plc's website uses cookies. By continuing to browse you are agreeing to our use of cookies. Find out more about our Cookie Policy.
MREO: US$3.40MPH: 58.00GBp
Working together to inspire, innovate and improve lives
17 SEP 2019Interim Financial Results for the Six Months Ended June 30, 2019 and Corporate UpdateConference Call
We continue to make strong progress in development of our product portfolio, in the hope of providing better treatment options for patients suffering from rare diseases
